BioMarin Pharmaceuticals
BMRN
BMRN
472 hedge funds and large institutions have $15.1B invested in BioMarin Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 149 increasing their positions, 187 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.23% less ownership
Funds ownership: 102% → 100.77% (-1.2%)
14% less capital invested
Capital invested by funds: $17.6B → $15.1B (-$2.43B)
20% less repeat investments, than reductions
Existing positions increased: 149 | Existing positions reduced: 187
Holders
472
Holding in Top 10
10
Calls
$138M
Puts
$119M
Top Buyers
| 1 | +$111M | |
| 2 | +$82M | |
| 3 | +$64.4M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$54.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.7M |
Top Sellers
| 1 | -$106M | |
| 2 | -$106M | |
| 3 | -$93.8M | |
| 4 |
BlackRock
New York
|
-$46.4M |
| 5 |
MNG
Manning & Napier Group
Fairport,
New York
|
-$34.5M |